High-potency statins and acute kidney injury-associated hospitalizations.
作者信息
Lenihan Colin R, Lafayette Richard A
机构信息
Stanford University School of Medicine, Stanford, California.
出版信息
Am J Kidney Dis. 2013 Nov;62(5):877-9. doi: 10.1053/j.ajkd.2013.07.006. Epub 2013 Aug 22.
Abstract
摘要
相似文献
1
High-potency statins and acute kidney injury-associated hospitalizations.高强度他汀类药物与急性肾损伤相关的住院治疗。
Am J Kidney Dis. 2013 Nov;62(5):877-9. doi: 10.1053/j.ajkd.2013.07.006. Epub 2013 Aug 22.
2
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.使用强效他汀类药物与急性肾损伤入院率：行政数据库的多中心回顾性观察性分析。
BMJ. 2013 Mar 18;346:f880. doi: 10.1136/bmj.f880.
3
High-potency statins increase the risk of acute kidney injury: evidence from a large population-based study.高剂量他汀类药物会增加急性肾损伤的风险：来自大型基于人群的研究证据。
Atherosclerosis. 2014 May;234(1):224-9. doi: 10.1016/j.atherosclerosis.2014.02.022. Epub 2014 Mar 15.
4
Statins for primary prevention of cardiovascular disease and the risk of acute kidney injury.他汀类药物用于心血管疾病一级预防和急性肾损伤的风险。
Pharmacoepidemiol Drug Saf. 2019 Dec;28(12):1583-1590. doi: 10.1002/pds.4898. Epub 2019 Sep 13.
5
[Do high potency statins lead to acute kidney injury?--Benefit of treatment with high dose statins has to be clarified].[强效他汀类药物会导致急性肾损伤吗？——高剂量他汀类药物治疗的益处有待明确]
Dtsch Med Wochenschr. 2013 May;138(20):1042. doi: 10.1055/s-0032-1329047. Epub 2013 May 13.
6
Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency.急性冠状动脉综合征患者的他汀类药物治疗：低密度脂蛋白胆固醇目标达标情况及他汀类药物效力的影响。
Ther Clin Risk Manag. 2015 Jan 23;11:127-36. doi: 10.2147/TCRM.S75608. eCollection 2015.
7
Statins and contrast-induced acute kidney injury with coronary angiography.他汀类药物与冠状动脉造影所致对比剂诱导的急性肾损伤
Am J Med. 2014 Oct;127(10):987-1000. doi: 10.1016/j.amjmed.2014.05.011. Epub 2014 May 20.
8
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.急性冠状动脉综合征后未使用高效他汀类药物的预测因素：来自达普拉替布稳定斑块-心肌梗死溶栓52（SOLID-TIMI 52）试验的见解
J Am Heart Assoc. 2017 Jan 11;6(1):e004332. doi: 10.1161/JAHA.116.004332.
9
High-potency statins are associated with increased hospitalisations with acute kidney injury.强效他汀类药物与急性肾损伤住院率增加有关。
Evid Based Med. 2014 Feb;19(1):28. doi: 10.1136/eb-2013-101357. Epub 2013 May 25.
10
The effects of preoperative statins on the incidence of postoperative acute kidney injury in patients undergoing cardiac surgeries.术前使用他汀类药物对接受心脏手术患者术后急性肾损伤发生率的影响。
Interact Cardiovasc Thorac Surg. 2015 Oct;21(4):493-8. doi: 10.1093/icvts/ivv194. Epub 2015 Jul 14.
引用本文的文献
1
The effect of the various doses of atorvastatin on renal tubular cells; an experimental study.不同剂量阿托伐他汀对肾小管细胞的影响：一项实验研究。
J Nephropathol. 2016 Jul;5(3):111-5. doi: 10.15171/jnp.2016.20. Epub 2016 Feb 14.
本文引用的文献
1
Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients.心脏手术术前他汀类药物治疗：9 万名患者的荟萃分析。
Eur J Cardiothorac Surg. 2014 Jan;45(1):17-26; discussion 26. doi: 10.1093/ejcts/ezt181. Epub 2013 Apr 5.
2
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.使用强效他汀类药物与急性肾损伤入院率：行政数据库的多中心回顾性观察性分析。
BMJ. 2013 Mar 18;346:f880. doi: 10.1136/bmj.f880.
3
Cholesterol limits lose their lustre.胆固醇限制措施失去了吸引力。
Nature. 2013 Feb 28;494(7438):410-1. doi: 10.1038/494410a.
4
Effect of statin use on acute kidney injury risk following coronary artery bypass grafting.他汀类药物使用对冠状动脉旁路移植术后急性肾损伤风险的影响。
Am J Cardiol. 2013 Mar 15;111(6):823-8. doi: 10.1016/j.amjcard.2012.11.047. Epub 2012 Dec 28.
5
Preoperative statin use and postoperative acute kidney injury.术前他汀类药物的使用与术后急性肾损伤。
Am J Med. 2012 Dec;125(12):1195-1204.e3. doi: 10.1016/j.amjmed.2012.06.021. Epub 2012 Oct 9.
6
Statins for all by the age of 50 years?50岁前人人都服用他汀类药物？
Lancet. 2012 Aug 11;380(9841):545-7. doi: 10.1016/S0140-6736(12)60694-1. Epub 2012 May 17.
7
The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.他汀类药物降低 LDL 胆固醇对低血管疾病风险人群的影响：27 项随机试验个体数据的荟萃分析。
Lancet. 2012 Aug 11;380(9841):581-90. doi: 10.1016/S0140-6736(12)60367-5. Epub 2012 May 17.
8
Three reasons to abandon low-density lipoprotein targets: an open letter to the Adult Treatment Panel IV of the National Institutes of Health.放弃低密度脂蛋白目标的三个理由：致国立卫生研究院成人治疗小组IV的公开信
Circ Cardiovasc Qual Outcomes. 2012 Jan;5(1):2-5. doi: 10.1161/CIRCOUTCOMES.111.964676.
9
Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system.他汀类药物相关的肌肉和肾脏不良事件：FDA 不良事件报告系统公开版本的数据挖掘。
PLoS One. 2011;6(12):e28124. doi: 10.1371/journal.pone.0028124. Epub 2011 Dec 20.
10
AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.美国心脏协会/美国心脏病学会基金会关于冠心病及其他动脉粥样硬化性血管疾病患者的二级预防和风险降低治疗：2011年更新版：由世界心脏联盟和心血管预防护士协会认可的美国心脏协会和美国心脏病学会基金会指南
J Am Coll Cardiol. 2011 Nov 29;58(23):2432-46. doi: 10.1016/j.jacc.2011.10.824. Epub 2011 Nov 3.
Zotero 插件